Cigna says its acquisition of Express Scripts is still on track to close by the end of the year, noting that the deal has been cleared by half of the states required to sign off.
The insurer plans to update investors over the next several weeks on the status of the $67 billion acquisition, according to a financial filing on Wednesday. Those discussions will include an update on federal and state approvals.
So far, the deal has been approved by 14 of the 29 states that have the authority to approve a “change in control” for an insurer.
The Department of Justice is still reviewing the transaction. This month, both parties certified “substantial compliance” with the DOJ’s second request for information in connection with the transaction.
RELATED: With merger vote approaching, Cigna and Express Scripts diverge on value-based contracts
“Cigna continues to anticipate that the merger will close by year-end 2018, subject to the satisfaction of all closing conditions, and looks forward to continuing to work cooperatively with the DOJ and the relevant states to discuss the many benefits of the transaction,” the filing states.
The disclosure comes days after Cigna and Express Scripts voted to approve the deal.